Literature DB >> 31004871

Sevoflurane Promotes Regeneration of the Endothelial Glycocalyx by Upregulating Sialyltransferase.

Satoshi Kazuma1, Yasuyuki Tokinaga2, Motonobu Kimizuka2, Ryu Azumaguchi2, Kohsuke Hamada2, Michiaki Yamakage2.   

Abstract

BACKGROUND: During ischemia-reperfusion injury, the endothelial glycocalyx is damaged by oxidative stress-induced release of hydrogen peroxide, leading to decreased endothelium-dependent vasodilation. The regenerative effects of sevoflurane on the endothelial glycocalyx and endothelium-dependent vasodilation in oxidative stress remain unclear. Sialic acid, which is a component of the glycocalyx, plays a key role in antioxidant activity and is catalyzed by the sialyltransferase, ST6Gal-I. We hypothesized that ST6Gal-I is involved in the sevoflurane-induced promotion of endothelial glycocalyx restoration and endothelium-dependent vasodilation after oxidative stress.
MATERIALS AND METHODS: To assess vasodilation, isometric tension in the rat aorta was measured. Aortic rings were treated with 0.5 mM hydrogen peroxide pre-exposure or post exposure to sevoflurane, with or without an ST6Gal-I inhibitor. The rings were then used for glycocalyx imaging using fluorescein isothiocyanate-labeled lectin staining and for immunohistochemistry for ST6Gal-I.
RESULTS: Vasodilation was significantly decreased by treatment with hydrogen peroxide compared to controls. Application of sevoflurane after treatment with hydrogen peroxide revived endothelium-dependent vasodilatation, whereas pretreatment with sevoflurane had no such effect. Sevoflurane after-treatment revived the intensity of fluorescence of the endothelial glycocalyx compared to the hydrogen peroxide group. However, pretreatment with sevoflurane had no such effect. Sevoflurane significantly upregulated the reduced expression of ST6Gal-I induced by hydrogen peroxide treatment.
CONCLUSIONS: Sevoflurane exerts regenerative effects on endothelium-dependent vasodilation and the endothelial glycocalyx following oxidative stress in the rat aorta.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelium-dependent vasodilation; Glycocalyx; Sevoflurane; Sialyltransferase

Mesh:

Substances:

Year:  2019        PMID: 31004871     DOI: 10.1016/j.jss.2019.03.018

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  1.2% Hydrogen gas inhalation protects the endothelial glycocalyx during hemorrhagic shock: a prospective laboratory study in rats.

Authors:  Tsunehisa Sato; Soichiro Mimuro; Takasumi Katoh; Tadayoshi Kurita; Sang Kien Truong; Kensuke Kobayashi; Hiroshi Makino; Matsuyuki Doi; Yoshiki Nakajima
Journal:  J Anesth       Date:  2020-01-30       Impact factor: 2.078

Review 2.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

3.  Anti-Inflammatory Activity of Orally Administered Monostroma nitidum Rhamnan Sulfate against Lipopolysaccharide-Induced Damage to Mouse Organs and Vascular Endothelium.

Authors:  Masahiro Terasawa; Keiichi Hiramoto; Ryota Uchida; Koji Suzuki
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

4.  Effect of sevoflurane and propofol on tourniquet-induced endothelial damage: a pilot randomized controlled trial for knee-ligament surgery.

Authors:  Felipe Maldonado; Diego Morales; Rodrigo Gutiérrez; Maximiliano Barahona; Oscar Cerda; Mónica Cáceres
Journal:  BMC Anesthesiol       Date:  2020-05-20       Impact factor: 2.217

Review 5.  Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.

Authors:  Tima Dehghani; Alyssa Panitch
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

Review 6.  The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases.

Authors:  Sheldon Weinbaum; Limary M Cancel; Bingmei M Fu; John M Tarbell
Journal:  Cardiovasc Eng Technol       Date:  2020-09-21       Impact factor: 2.495

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.